Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
09/2002
09/24/2002US6455704 Reacting carbazole with butyllithium in hydrocarbon solvent forming intermediate, then reacting with potassium butoxide
09/24/2002US6455587 Aromatic sulfonyl derivatives
09/24/2002US6455581 Inhibitors of hiv protease.
09/24/2002US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/24/2002US6455502 Compounds and compositions as protease inhibitors
09/24/2002CA2246584C Method of treating tourette's syndrome
09/24/2002CA2096223C Treatment for tissue ulceration
09/20/2002WO2001070687A1 Indoles for treating diseases that can be treated using thyroid hormones
09/20/2002CA2403806A1 Indoles for treating diseases that can be treated using thyroid hormones
09/19/2002WO2002072549A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
09/19/2002WO2002072548A2 Heterocyclic compounds and their use as histamine h4 ligands.
09/19/2002WO2002072547A1 Amination process
09/19/2002WO2002072532A1 7, 9-substituted tetracycline compounds
09/19/2002WO2002072068A2 Lipids, lipid compositions, liposomes, and lipoplexes
09/19/2002WO2002071827A2 Retinoid x receptor modulators
09/19/2002WO2002053534A8 Vla-4 inhibitors
09/19/2002WO2002050028A3 Substituted benzoindoles as spla2 inhibitors
09/19/2002WO2002024194A9 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
09/19/2002US20020133007 Potato and corn crops
09/19/2002US20020132833 Caspase inhibitors and uses thereof
09/19/2002US20020132792 Aryl-substituted indirubin derivatives, their production and use
09/19/2002DE10112882A1 Selective cytostatic treatment of serotonin-producing tumors, using non-toxic tryptophan derivatives, e.g. 7-hydroxytryptophan, which are enzymatically converted into specific toxins in the tumor cells
09/19/2002DE10109204A1 Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway
09/19/2002CA2438586A1 Retinoid x receptor modulators
09/18/2002EP1240157A2 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect
09/18/2002EP1240154A1 Serine protease inhibitors
09/18/2002EP1036059B1 Adamantane derivatives
09/18/2002EP0994854B1 Method for preparing a substituted perhydroisoindole
09/18/2002EP0975594B1 Process for the production of indole derivatives
09/18/2002EP0888322B1 Electrophilic ketones for the treatment of herpesvirus infections
09/18/2002EP0837847B1 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
09/18/2002EP0823889B1 1,3-propane diol derivatives as bioactive compounds
09/18/2002EP0804427B1 Lta4 hydrolase inhibitors
09/18/2002EP0700388B1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors
09/18/2002CN1370173A Isomeric fused pyrrolocarbazoles and isoindolones
09/18/2002CN1370159A Indole derivatives and their use for treatment of osteoporosis amongst other applications
09/18/2002CN1091097C Process for preparing N-substuted glacinic acids or glycinic esters
09/17/2002US6452004 Useful as an intermediate of a carbocyclic nucleoside usefully used as an anti-viral agent
09/17/2002US6451843 Arylphenyl-substituted cyclic keto enols
09/17/2002US6451842 Cyclic amine derivatives and their use as drugs
09/17/2002US6451839 Indole sPLA2 inhibitors
09/17/2002US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451829 Coumarinic compounds having IgE affecting properties
09/17/2002US6451827 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
09/17/2002US6451824 Sulfonylaminocarboxylic acids
09/17/2002US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451819 Pyrrolidine-3-yl-sulfanyl, or sufonyl or sufinyl derivatives used in the treatment of neurodegenerative diseases
09/17/2002US6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders
09/17/2002US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/17/2002US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
09/17/2002US6451724 Bis(n-methyl-5,10-dihydroindeno(1,2-b)indol-10 -yl)titanium dichloride
09/17/2002US6451461 Hole transporting compounds having good thermal stability for organic electroluminescent device and method for production thereof
09/17/2002CA2057338C Diarylfluoromethane compounds
09/17/2002CA2048096C N-benzyl-indoles
09/12/2002WO2002070541A2 Peptide deformylase inhibitors
09/12/2002WO2002070478A1 Indolone derivatives having vascular-damaging activity
09/12/2002WO2002070477A1 2-methylindole-4-acetic acid, process for producing the same, and process for producing intermediate therefor
09/12/2002WO2002070468A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
09/12/2002WO2002070467A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
09/12/2002WO2002070464A2 Hydrazones and their therapeutic use
09/12/2002WO2002070439A2 Amination process
09/12/2002WO2002069947A2 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer
09/12/2002WO2002069901A2 Cathepsin cysteine protease inhibitors
09/12/2002WO2002050030A3 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
09/12/2002WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses
09/12/2002WO2001045681A3 Naphthoquinone derivatives as cd45 inhibitors
09/12/2002WO2001012600A9 INHIBITORS OF FACTOR Xa
09/12/2002US20020128510 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines
09/12/2002US20020128499 Alkylthio-substituted benzoquinones by oxidizing with an alkali periodate in the presense of a phase transfer catalyst; Protective agents for rubber vulcanizates; aging and ozone resistance; fatigue; stabilizers
09/12/2002US20020128490 Amination process
09/12/2002US20020128483 Sulfonamide-containing indole compounds
09/12/2002US20020128480 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents
09/12/2002US20020128315 Amidinophenol derivatives as leukotriene B4 (LTB4)antagonists, phospholipase A2 inhibitors, and trypsin inhibitors.
09/12/2002US20020128274 Benzylpiperazinyl-indolinylethanones
09/12/2002US20020128263 Treatment or prevention of mGluR5 receptor mediated disorders.
09/12/2002US20020128261 Cyclohepta [b] [1,4] diazepino [6,7, 1-hi] indoles and derivatives
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002US20020128247 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents
09/12/2002US20020128236 Substituted fused pyrroleoximes and fused pyrazoleoximes
09/12/2002US20020128206 Such as 6-Amino-2-(2-((1-benzenesulfonyl-piperidine-4-carbonyl)-amino)-3-(1H-indol-3-yl)-propionylamino)-hexanoic acid tert-butyl ester for promotes secretion of growth hormone; gene expression
09/12/2002US20020128149 Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst
09/12/2002US20020127202 Compounds and compositions for delivering active agents
09/12/2002CA2439827A1 Peptide deformylase inhibitors
09/12/2002CA2434601A1 Methods for specifically inhibiting histone deacetylase-4
09/11/2002EP1238973A1 Novel substituted tricyclic compounds
09/11/2002EP1238972A1 Novel carbazole derivative and chemically amplified radiation-sensitive resin composition
09/11/2002EP1238971A1 Substituted guanidine derivatives
09/11/2002EP1238704A2 Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst
09/11/2002EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators
09/11/2002EP1237879A1 Phenoxy and thiophenoxy acrylic acid compounds as herbicides
09/11/2002EP1237869A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
09/11/2002EP1237849A1 Activators of soluble guanylate cyclase
09/11/2002CN1368960A Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application
09/11/2002CN1368883A Method for reducing serum glucose and trigluceride and inhibiting vascular formation by indolealkanoic acids
09/11/2002CN1090632C Intermediates for preparation of duocarmycin SA and derivatives thereof, and process for production of intermdiates
09/10/2002USRE37839 Fungicides, insecticides, miticides, nematocides, and pesticides
09/10/2002US6448413 17-hydroxy-17-methyl-1,3-seco-2-nor-5-androstane-3-acid derivatives from mestanolone and aromatic nitro-aldehyde
09/10/2002US6448412 Combinatorial chemistry libraries
09/10/2002US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease
09/10/2002US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein